Skip to content
Screener

Reported November 12, 2025 · Before market open

EPS-$0.12Beat by $0.05
EPS estimate-$0.17

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.1M
EPS estimate-$0.20

FAQ

When did Milestone Pharmaceuticals report Q3 2025 earnings?
Milestone Pharmaceuticals (MIST) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Milestone Pharmaceuticals's Q3 2025 revenue and EPS?
Milestone Pharmaceuticals reported eps of $-0.12 for Q3 2025.
Did Milestone Pharmaceuticals beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.17 by $0.05.
How did Milestone Pharmaceuticals's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 14.3% from $-0.14.
Where can I find Milestone Pharmaceuticals's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-109744) and the 10-Q periodic report (0001104659-25-109689) directly on SEC EDGAR. The filing index links above go to sec.gov.